Purchase Order 75F40126P00150
Award Date 8/1/26
Potential Completion Date 4/30/27
Potential Value $143K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Metairie, LA 70006, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration awarded a purchase order to Emulate Inc. for $45,000 on August 28, 2025, for the procurement of organ-on-chip culture modules, specifically two Emulate Zoe CM1 units and one Orb Hub Module-1. The contract is structured as a firm fixed-price purchase order with an ultimate completion date of August 28, 2026, and performance will take place at the FDA's facility in Silver Spring, Maryland. No set-aside designation was used for this award. Emulate Inc., a...
- This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $24,250.00, is for the delivery of Brainbox LTD's NEUROFUS DEEP TRANSDUCER, a specialized medical device used to modulate neural activity in deeper areas of the human brain. This technology supports NIDA's research efforts, which include the study of addiction and other neurological conditions. The...
- The Food and Drug Administration awarded a $248,000 firm fixed price purchase order to Emulate Inc. for Emulate Chip-S1 Basic Research Kits on September 19, 2025. The contract, with an ultimate completion date of September 18, 2026, will be performed at the FDA's Silver Spring, Maryland location. No set-aside designation was applied to this procurement. Emulate Inc., headquartered in Boston, Massachusetts, is a biotechnology company specializing in organ-on-chip microphysiological systems that...
- The Food and Drug Administration awarded a purchase order to Emulate Inc. for five liver human emulation system 24-pack quad liver chip kits, valued at $104,500, on June 27, 2023, under a Total Small Business set-aside. Performance is to occur in Boston, Massachusetts, with an ultimate completion date of June 26, 2024. The procurement is for firm fixed-price commercial organ-on-chip microphysiological systems designed to support biomedical research and regulatory science applications,...
- <p>The National Center for Advancing Translational Sciences awarded a purchase order to 3Dnamics Inc. for $24,000 on February 4, 2021, for lab testing services involving the generation of 90-day midbrain organoids for RNA and protein work. The order carries no small business set-aside. Work is performed at 3Dnamics' facility in Baltimore, Maryland, with an ultimate completion date of May 31, 2021. The order is firm fixed price.</p>
- The U.S. Food and Drug Administration awarded a $200.3K purchase order to Emulate Inc., a Boston-based biotechnology company specializing in organ-on-chip microphysiological systems, for the procurement of a Human Emulation System. The contract, awarded on March 29, 2023, with an ultimate completion date of October 1, 2023, carries a Total Small Business set-aside designation and employs firm fixed-price pricing. The award supports FDA's regulatory science initiatives and efforts to advance...
- The Food and Drug Administration awarded a $31,950 purchase order to Emulate Inc. on June 18, 2025, for twelve Chip-R1 Rigid Chip basic research kits under a total small business set-aside designation. The contract, which extends to October 16, 2025, represents a firm fixed price procurement of the company's organ-on-chip technology. Emulate Inc., headquartered in Boston, Massachusetts, specializes in microphysiological systems that replicate human organ functions to support advanced...
- This is a firm-fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Brain Research And Development Services LTD, a foreign-owned for-profit organization that manufactures goods. The contract has a ceiling value of $90,000.00 and a period of performance through May 30, 2017. It does not have a set-aside designation. The contract was awarded on September 24, 2015 and is related to the BRAIN (Brain Research through Advancing Innovative...
- This $17,575 firm fixed price purchase order was awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency within the U.S. Department of Health and Human Services, to Brainxell, Inc., a for-profit manufacturer of human neuron cells. The contract is for the provision of CRISPR engineered cells to support neurological disease research and drug discovery. Brainxell has previously received other federal contract and grant awards from NIH institutes for projects...
- The Food and Drug Administration awarded a purchase order to Sentrysciences, Inc. valued at $55,000 on June 15, 2026 for an artificial intelligence and computational statistics platform to detect and classify protein aggregates in biosimilar drug products. Work is performed in Silver Spring, Maryland. The platform combines machine learning to generate morphological fingerprints of protein aggregates, differentiate particles by stress type and product, and employ neural network-based metric...